MGMT functions as a tumour suppressor gene, with its promoter frequently methylated when IDH mutations are present; thus, methylation of the promoter of MGMT is frequently observed in oligodendrogliomas and astrocytomas. Here, IDH1 is linked to oligodendroglioma.